 Quest Diagnostics Inc NYSE: DGX expects Q4 sales of 2.74 billion, a decrease of 9 YY, beating the consensus of 2.54 billion. The company noted preliminary Q4 results reflect higher than expected demand for COVID-19 testing services, while base testing volumes remained steady and consistent with the previous outlook. 